¿Qué es este ingrediente?

이 원료는 평균 12-15개의 탄소원자로 구성된 곧은 사슬, 고리형 및 방향족 탄화수소의 혼합물이다.

Diccionario de ingredientes

C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONS

Solvent naphtha (petroleum) heavy aromatic.

Definición

Solvent naphtha (petroleum) heavy aromatic. A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C12-15

Funciones cosméticas

Base que disuelve otros ingredientesSOLVENT

Referencias de seguridad y regulación

Sin clasificación en la lista GHS de sustancias tóxicas de Corea · sustancia química existente

Fuente: Registro GHS de sustancias tóxicas de Corea (NIER)

Other restriction: ban substances that deplete the ozone layer

Fuente: Lista de ingredientes CosIng (UE)

Más datos: nombres, identificadores, propiedades, ensayos y literatura

Nombres e identificadores

C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONSINCIC12-15알케인/사이클로알케인/아로마틱하이드로카본Nombre en etiquetas coreanas (estándar MFDS)Solvent naphtha (petroleum), heavy arom.Sinónimo

CAS No.número de registro químico: 64742-94-5
EC No.número de inventario químico de la UE: 265-198-5
DTXSIDidentificador químico de la EPA (EE. UU.): DTXSID9028251

Para qué lo usan los productos

Usos de los 36 productos declarados ante la EPA de EE. UU. con este ingrediente. Incluye productos que no son cosméticos, así que las primeras filas son sus usos principales.

Solvent16
Processing aids not otherwise specified4
Lubricating agent4
Binder2
Surfactant (surface active agent)2
Defoamer2
Fuel agents2
Viscosity modifier1

3 usos más

Dispersing agent1
Fuel1
Demulsifier1

Fuente: Panel CompTox de la EPA

Estudios de irritación y sensibilización

Constan 15 estudios en piel y 8 en ojos.

Clasificado como muy irritante12Clasificado como moderado1Clasificado como bajo18

Los estudios no coinciden (la conclusión más frecuente reúne el 39%), así que no demuestran que el ingrediente sea irritante. Son ensayos de la materia prima en sí; la irritación a la cantidad de un producto terminado es otra cuestión.

Ver los 23 estudios

Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs 44054-44093 according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to EPA OTS 798.4100 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs. 44054-44093
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs 44054-44093
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Severe Irritation
skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to
Category 2
Skin Irritation · Screening
Severe Irritation
skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Classification not possible
Skin Sensitization · Screening
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) according to
Category 2
Eye Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to